Virtu Financial LLC Sage Therapeutics, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$18.62 - $26.95 $186,255 - $269,580	10,003 New	10,003 $187,000
Q2 2023 Jul 27, 2023	BUY	$40.65 - $59.54 $723,285 - $1.06 Million	17,793 New	17,793 $837,000
Q2 2020 Aug 07, 2020	SELL	$25.95 - $43.15 $263,055 - $437,411	-10,137 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$60.18 - $154.77 $495,100 - $1.27 Million	8,227 Added 430.73%	10,137 $732,000
Q3 2019 Nov 20, 2019	BUY	$140.29 - $189.96 $267,953 - $362,823	1,910 New	1,910 $268,000
Q4 2018 Jan 16, 2019	SELL	$81.94 - $139.71 $401,096 - $683,880	-4,895 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $177,333 - $217,047	1,284 Added 35.56%	4,895 $691,000
Q1 2018 May 14, 2018	BUY	$152.15 - $192.33 $549,413 - $694,503	3,611 New	3,611 $582,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.